| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/17/2006 | CN1774266A Liquid formulations of tumor necrosis factor-binding proteins. |
| 05/17/2006 | CN1774263A Long acting injectable insulin composition and methods of making and using thereof |
| 05/17/2006 | CN1774262A Pharmaceutical composition containing interferon for the treatment of HPV infections |
| 05/17/2006 | CN1774261A Methods and compositions for the treatment of diseases of the eye |
| 05/17/2006 | CN1774260A Use of repeat sequence protein polymers in personal care compositions |
| 05/17/2006 | CN1774259A Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 05/17/2006 | CN1774258A Treatment of pulmonary disease |
| 05/17/2006 | CN1772897A Cell factor with several functions |
| 05/17/2006 | CN1772312A Wound dressing for first aid |
| 05/17/2006 | CN1772292A Nutrient for preventing sudden death |
| 05/17/2006 | CN1772291A Nanometer granule prepn of bufanin albumin and its prepn process |
| 05/17/2006 | CN1772290A Nanometer granule prepn of cinobufagin toxoprotein and its prepn process |
| 05/17/2006 | CN1772289A Expanding diuretic for treating pulmonary edema in perioperative period of hepatic and biliary diseases |
| 05/17/2006 | CN1772288A Recipe of skin repairing composition |
| 05/17/2006 | CN1772287A Application of hedgehog fungus mycelium glucoprotein in preparing medicine |
| 05/17/2006 | CN1772286A Vital energy benefiting and blood nourishing medicine composition |
| 05/17/2006 | CN1771912A Orally taken nanometer protein polypetide composition particle and its prepn |
| 05/17/2006 | CN1771905A Oral cavity freshener containing herbal material and biological antibacterial peptide |
| 05/17/2006 | CN1256606C Metal die and manufacture thereof |
| 05/17/2006 | CN1256347C Fusion protein of kininogen D5 and tumor necrosis factor related apoptosis-inducing ligand(D5-TRAIL), its preparation and use thereof |
| 05/17/2006 | CN1256147C CD8 as inhibitor of cellular immune system |
| 05/17/2006 | CN1256146C Aqueous formulations of LHRH related peptide compound and preparing method and use thereof |
| 05/17/2006 | CN1256080C In-situ gel formation of pectins |
| 05/17/2006 | CN1256076C Preserving hemoglobin blood substitute with transparent overwrap and product thereof |
| 05/17/2006 | CN1256029C Use of food as delevery system for phytase in humans |
| 05/16/2006 | US7045683 Δ4-desaturase genes and uses thereof |
| 05/16/2006 | US7045675 Protein for use in the diagnosis and detection of Niemann-Pick disease |
| 05/16/2006 | US7045636 MCH antagonists for the treatment of obesity |
| 05/16/2006 | US7045617 Bisbubstrate inhibitors of kinases |
| 05/16/2006 | US7045615 Nucleic acids encoding JTT-1 protein |
| 05/16/2006 | US7045614 LIM mineralization protein splice variants |
| 05/16/2006 | US7045613 IKK-αproteins, nucleic acids and methods |
| 05/16/2006 | US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies |
| 05/16/2006 | US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045601 Complexing with metal compound and complexing agent |
| 05/16/2006 | US7045600 Relates to gene procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 which codes for telopeptide lysyl hydroxylase which converts telopeptidyl lysine into telopeptidyl hydroxylysine that can be converted to hydroxyallysine |
| 05/16/2006 | US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045594 Serine proteinase inhibitors |
| 05/16/2006 | US7045593 Using detergents; antiagglomerants; eukaryotic membrane protein |
| 05/16/2006 | US7045592 In situ chlorination, to generate amino acid chlorides, utilizing for solid phase peptide synthesis |
| 05/16/2006 | US7045591 Cyclic peptide for use in the treatment of eating disorders |
| 05/16/2006 | US7045552 Aqueous formulation of fusion inhibitor and polyol; minimizes number of injections and site reaction |
| 05/16/2006 | US7045543 Insertion drugs into cells, tissue; therapy for brain disorders, central nervous system disorders |
| 05/16/2006 | US7045537 Polypeptide coiled strands; crosslinking |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 05/16/2006 | US7045504 Cyclic peptidomimetic urokinase receptor antagonists |
| 05/16/2006 | US7045503 Radiometal-binding peptide analogues |
| 05/16/2006 | US7045502 Administering concurrent with cell grafting surgery using insulin producing stem cells |
| 05/16/2006 | US7045501 Method of treating chronic cardiac disease |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045498 Soluble Zcytor11 cytokine receptors |
| 05/16/2006 | US7045497 Use of peptide |
| 05/16/2006 | US7045351 Comprises protein with mitogenic/dual oxidase activity for stimulating production of oxygen intermediates such as superoxide; drug screening |
| 05/16/2006 | US7045350 Alternatively spliced circulating tissue factor |
| 05/16/2006 | US7045346 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 05/16/2006 | US7045345 G-coupled receptor showing selective affinity for ATP |
| 05/16/2006 | US7045337 Translation system for use in the generation of protein containing adjusted amino acid sequences |
| 05/16/2006 | US7045333 Human protease molecules |
| 05/16/2006 | US7045329 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/16/2006 | US7045326 Mono- and diacylglycerol acyltransferases and methods of use thereof |
| 05/16/2006 | US7045323 Glutathione reductase for therapy and prophylaxis of aids |
| 05/16/2006 | US7045318 Recombinant fusion proteins to growth hormone and serum albumin |
| 05/16/2006 | US7045315 Methods for modulating expression of exogenous genes in mammalian systems |
| 05/16/2006 | US7045306 assay comprising transcriptional and cognate activators with Huntington's disease mutant protein; linked to detectable sequence within neuron; for preventing or treating a neurodegenerative disease associated with an expanded polyglutamine tract |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045300 Isolated, purified plant extract; anticancer agents; bonding n-acetylneuraminic acid to protein |
| 05/16/2006 | US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ |
| 05/16/2006 | US7045293 Alteration of sequence of a target molecule |
| 05/16/2006 | US7045155 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia |
| 05/16/2006 | US7045141 Allograft bone composition having a gelatin binder |
| 05/16/2006 | US7045135 Composition of koji of rice bran and non-propagating lactic acid bacteria, methods of use, and manufacturing method thereof |
| 05/16/2006 | US7045133 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/16/2006 | US7045128 Antibodies against flt3-ligand |
| 05/16/2006 | US7045126 Genetic engineering; isolation polypeptides; heterogeneity amino acid sequences |
| 05/16/2006 | CA2527154A1 Blood-viscosity reducing agent |
| 05/16/2006 | CA2291274C Uses of oil bodies |
| 05/16/2006 | CA2260296C Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule |
| 05/16/2006 | CA2171276C Use of human recombinant interleukin-1 receptor antagonist and composition containing the latter for the treatment of osteoarthritis and composition containing said compound |
| 05/16/2006 | CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens |
| 05/11/2006 | WO2006050498A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 05/11/2006 | WO2006050421A1 Prodrugs of ribavirin with improved hepatic delivery |
| 05/11/2006 | WO2006050328A1 Improved quenching methods for red blood cell inactivation process |
| 05/11/2006 | WO2006050280A2 Anti-respiratory syncytial virus antibodies, antigens and uses thereof |
| 05/11/2006 | WO2006050275A2 Rapid species-specific detection of pathogens |
| 05/11/2006 | WO2006050269A2 Injection of fibrin sealant using reconstituted components in spinal applications |
| 05/11/2006 | WO2006050267A2 Injection of fibrin sealant including an anesthetic in spinal applications |
| 05/11/2006 | WO2006050250A2 Dose forms comprising vx-950 and their dosage regimen |
| 05/11/2006 | WO2006050247A2 Remodeling and glycopegylation of fibroblast growth factor (fgf) |
| 05/11/2006 | WO2006050183A2 Inhibitors of sporeforming pathogens and applications of the same |
| 05/11/2006 | WO2006050155A2 Cancer therapeutic compositions |
| 05/11/2006 | WO2006050123A1 Spontaneously dispersible pharmaceutical compositions |
| 05/11/2006 | WO2006050041A2 Methods for reducing or inhibiting brain inflammation or for promoting neurogenesis |
| 05/11/2006 | WO2006049681A2 Selective neuropeptide y2 receptor agonists |
| 05/11/2006 | WO2006049490A1 Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointima |
| 05/11/2006 | WO2006049312A1 Remedy for neuropathic pain |
| 05/11/2006 | WO2006049307A1 Liposome and method of injecting substance into cell by using the same |
| 05/11/2006 | WO2006049304A1 Aryloxy-substituted benzimidazole derivatives |
| 05/11/2006 | WO2006048862A2 The use of a protease or a protease inhibitor for the manufacture of medicaments |